Silence Therapeutics plc Increase (Decrease) in Contract with Customer, Liability
Silence Therapeutics plc (SLNCF) reported Increase (Decrease) in Contract with Customer, Liability of -$404.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-08-10
- Silence Therapeutics plc increase (decrease) in contract with customer, liability for the quarter ending 2026-06-30 was $0.00.
- Silence Therapeutics plc increase (decrease) in contract with customer, liability for the quarter ending 2026-03-31 was -$404.00K.
- Silence Therapeutics plc increase (decrease) in contract with customer, liability for the quarter ending 2025-12-31 was -$32.00K.
- Silence Therapeutics plc increase (decrease) in contract with customer, liability for the quarter ending 2025-09-30 was -$88.00K.
- Silence Therapeutics plc increase (decrease) in contract with customer, liability for fiscal 2025 was -$334.00K.
- Silence Therapeutics plc increase (decrease) in contract with customer, liability for fiscal 2024 was -$28.79M.
- Silence Therapeutics plc increase (decrease) in contract with customer, liability for fiscal 2023 was -$10.32M.
- Silence Therapeutics plc increase (decrease) in contract with customer, liability for fiscal 2022 was -$5.44M.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$404.00K 10-Q · filed 2026-08-10 | -$436.00K derived: sum of 3 quarters · filed 2026-08-10 | -$524.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | -$404.00K 10-Q · filed 2026-05-07 | -$436.00K derived: sum of 2 quarters · filed 2026-05-07 | -$524.00K derived: sum of 3 quarters · filed 2026-05-07 | -$666.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | -$32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$120.00K derived: sum of 2 quarters · filed 2026-03-05 | -$262.00K derived: sum of 3 quarters · filed 2026-08-10 | -$334.00K 10-K · filed 2026-03-05 |
| 2025-09-30 | -$88.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$230.00K derived: sum of 2 quarters · filed 2026-08-10 | -$302.00K 10-Q · filed 2025-11-06 | -$24.46M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | -$142.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$214.00K 10-Q · filed 2026-08-10 | -$24.37M derived: sum of 3 quarters · filed 2026-08-10 | -$25.06M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | -$72.00K 10-Q · filed 2026-05-07 | -$24.23M derived: sum of 2 quarters · filed 2026-05-07 | -$24.92M derived: sum of 3 quarters · filed 2026-05-07 | -$23.34M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$24.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$24.84M derived: sum of 2 quarters · filed 2026-03-05 | -$23.27M derived: sum of 3 quarters · filed 2026-03-05 | -$28.79M 10-K · filed 2026-03-05 |
| 2024-09-30 | -$684.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $889.00K derived: sum of 2 quarters · filed 2025-11-06 | -$4.63M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $1.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$3.94M 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | -$5.51M 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | -$10.32M 10-K · filed 2025-02-27 | |||
| 2022-12-31 | -$5.44M 10-K · filed 2025-02-27 |